PD pathway-mediated evasion of tumor immunity is described as “adaptive resistance” since PD-L1 is absent in most normal tissues, while IFN-γ can induce its expression in virtually any nucleated cells (13–17). This evidence concerns the gene CD274 and neoplasm.